Is the new strain of SARS-CoV-2 more infectious than the last?
Researchers have identified a specific change in the SARS-CoV-2 coronavirus spike protein that may increase its transmission, making it more infectious in cell culture.
Browsing: Outbreaks
COVID-19 research round-up: June
This month’s top COVID-19 research articles include several studies citing the benefits of facemasks, as well as research investigating adaptive immunity to SARS-CoV-2 and a genome-wide study exploring COVID-19 severity.
SARS-CoV-2 can infect human myocardiocytes in vitro
Researchers at Cedars-Sinai Medical Center have discovered that SARS-CoV-2 can infect human myocardiocytes in vitro. COVID-19 infection can cause heart problems. This study demonstrates that this could be due to direct infection of myocardiocytes by the virus.
Confronting COVID-19 head on at the Wyss Institute
Harvard’s Wyss Institute is leveraging its unique technology innovation capabilities to develop diagnostic, therapeutic, and vaccine interventions for COVID-19 at lightning speed.
Researchers identify inflammatory molecules as potential targets for COVID-19
Researchers have accurately profiled the immune response to COVID-19 in critically ill patients, allowing them to identify six inflammatory molecules as potential targets for COVID-19 treatment.
Adaptive study design and the potential of convalescent plasma therapy for COVID-19 – an interview with José Javier García
In this interview we speak to José Javier García from Pivotal about his company´s involvement in a large-scale clinical trial testing the safety and efficacy of hyperimmune convalescent plasma treatment in COVID-19 patients.
A peek behind the paper – Wenqing Jiang on the application of evolutionary theories to SARS-CoV-2
Take a peek behind the scenes of a recent article published by Future Virology, titled ‘Pros…
A peek behind the paper – John Nemunaitis on targeting furin to tackle SARS-CoV-2
Take a look behind the scenes of a recent Future Virology paper, titled ‘Severe acute respiratory syndrome…
Highly potent human antibodies neutralize COVID-19 in animal tests
Researchers at Scripps Research Institute have used the blood of recovered COVID-19 patients to identify potent antibodies that protect against SARS-CoV-2. The study, published in Science, has shown the antibodies’ successful use in animal models and human cell cultures.
Patients with severe COVID-19 may benefit from dexamethasone treatment
Dexamethasone, a steroid drug typically used to treat inflammation in conditions such as arthritis and asthma, has recently been tested as part of the Recovery trial at Oxford University (UK), and results are looking positive.
